Cytosorbents Corporation盘中异动早盘急速拉升9.72%报0.920美元

市场透视2024-12-24

北京时间2024年12月24日22时32分，Cytosorbents Corporation（CTSO.us）股票出现波动，股价急速上涨9.72%。截至发稿，该股报0.920美元/股，成交量6095股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入9.39百万美元，净利润-2.33百万美元，每股收益-0.04美元，毛利5.28百万美元，市盈率-2.43倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2493087928?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-24 22:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2493087928","market":"us","top_or_hot":-1,"title":"Cytosorbents Corporation盘中异动 早盘急速拉升9.72%报0.920美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月24日22时32分，Cytosorbents Corporation（CTSO.us）股票出现波动，股价急速上涨9.72%。截至发稿，该股报0.920美元/股，成交量6095股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入9.39百万美元，净利润-2.33百万美元，每股收益-0.04美元，毛利5.28百万美元，市盈率-2.43倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cytosorbents Corporation盘中异动 早盘急速拉升9.72%报0.920美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCytosorbents Corporation盘中异动 早盘急速拉升9.72%报0.920美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-24 22:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月24日22时32分，Cytosorbents Corporation（CTSO.us）股票出现波动，股价急速上涨9.72%。截至发稿，该股报0.920美元/股，成交量6095股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入9.39百万美元，净利润-2.33百万美元，每股收益-0.04美元，毛利5.28百万美元，市盈率-2.43倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b","article_id":"2493087928","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2493087928","pubTimestamp":1735050779,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月24日22时32分，Cytosorbents Corporation股票出现波动，股价急速上涨9.72%。截至发稿，该股报0.920美元/股，成交量6095股，换手率0.01%，振幅0.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.16%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4082":"医疗保健设备","CTSO":"Cytosorbents Corporation"},"translate_title":"Cytosorbents Corporation surged 9.72% to $0.920 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTSO":1},"content_text":"北京时间2024年12月24日22时32分，Cytosorbents Corporation（CTSO.us）股票出现波动，股价急速上涨9.72%。截至发稿，该股报0.920美元/股，成交量6095股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入9.39百万美元，净利润-2.33百万美元，每股收益-0.04美元，毛利5.28百万美元，市盈率-2.43倍。机构评级方面，在所有2家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.16%。其相关个股中，Tivic Health Systems, Inc.、Trisalus Life Sciences Inc C/Wts 10/08/28 (To Pur Com)、Avita Medical, Inc.涨幅较大，Tivic Health Systems, Inc.、Helius Medical Technologies, Inc.、Aethlon Medical, Inc.较为活跃，换手率分别为576.41%、2.72%、1.95%，振幅较大的相关个股有Tivic Health Systems, Inc.、Lensar, Inc.、Sera Prognostics, Inc.，振幅分别为27.72%、8.21%、6.98%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。收入主要来自德国的产品销售，还有来自于美国资助机构的额外收入。该公司通过直销、分销商/战略合作伙伴和政府部门运营。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493087928","isCrawlerRequest":true}

Cytosorbents Corporation盘中异动 早盘急速拉升9.72%报0.920美元

精彩评论

Cytosorbents Corporation盘中异动早盘急速拉升9.72%报0.920美元